Investigating Hearing Aid Frequency Response Curves

NCT05521308 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2025-03-24

Study results available
· View outcomes & findings →

Summary

Internal research on the manufacturer's hearing aid products has idenitfied areas in which the investigators can improve the hearing aid frequency response curve. This study aims to investigate the current freqeuncy response curve in the manufacturer's products to variations of these curves to determine if hearing aid users prefer the variations over the manufacturer's standard curve.

Conditions

  • Hearing Loss, Sensorineural
  • Hearing Loss, Bilateral

Interventions

DEVICE

Hearing Aid - Standard Curve

Our current hearing aids which will be programmed to our standard frequency response curve.

DEVICE

Hearing Aid - Variation #1

Hearing aids that will have the frequency response curve adjusted and fit to the participant's hearing loss.

DEVICE

Hearing Aid - Variation #2

Hearing aids that will have the frequency response curve adjusted and fit to the participant's hearing loss.

DEVICE

Hearing Aid - Variation #3

Hearing aids that will have the frequency response curve adjusted and fit to the participant's hearing loss.

DEVICE

Hearing Aid - Variation #4

Hearing aids that will have the frequency response curve adjusted and fit to the participant's hearing loss.

Sponsors & Collaborators

  • Sonova AG

    lead INDUSTRY

Principal Investigators

  • Jinyu Qian, PhD · Sonova AG

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-24
Primary Completion
2023-01-11
Completion
2023-01-11

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05521308 on ClinicalTrials.gov